Clearance Summary
APPALEAD GW+03XXXXXXR SERIES received FDA 510(k) clearance under submission number K003394, sponsored by Nipro Medical Corp.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2001-01-30.
- Submission: K003394
- Applicant / Sponsor: Nipro Medical Corp.
- Clearance pathway: Abbreviated
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1330
- Decision date: 2001-01-30
Classification & Regulation
This clearance is catalogued under FDA product code DQX and 21 CFR 870.1330, within the Cardiovascular review panel as a Class II device.